Union, NJ, United States of America

Kanaiyalal R Patel

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Kanaiyalal R Patel

Introduction

Kanaiyalal R Patel is a notable inventor based in Union, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable formulations for bortezomib. With a total of four patents to his name, Patel's work has the potential to enhance the efficacy and stability of important medical treatments.

Latest Patents

Patel's latest patents focus on multi-dose formulations for bortezomib, which demonstrate significantly improved stability. These formulations are particularly advantageous as they present bortezomib in a liquid form suitable for injection. The solvent system predominantly comprises propylene glycol, which contributes to the stability of the formulation. Additionally, in some preferred aspects, bortezomib is present as a Lewis donor-acceptor complex with a hetero-bifunctional Lewis base, further enhancing its effectiveness.

Career Highlights

Kanaiyalal R Patel is currently associated with Innopharma, Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving drug formulations, which can lead to better patient outcomes.

Collaborations

Patel has collaborated with notable colleagues, including Kumaresh Soppimath and Satish K Pejaver, to advance his research and development efforts. These collaborations have played a crucial role in the success of his innovative projects.

Conclusion

Kanaiyalal R Patel's contributions to the field of pharmaceuticals through his patents on bortezomib formulations highlight his role as a significant inventor. His work not only showcases his expertise but also has the potential to impact medical treatments positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…